Alzheimer'S Disease Clinical Trials in Tampa, FL

Alzheimer'S Disease Clinical Trials in Tampa, FL

View the best 10 alzheimer's disease medical studies in Tampa, Florida. Access promising new therapies by applying to a Tampa-based Alzheimer'S Disease clinical trial.

Trials in Tampa, Florida

Here are the top 10 medical studies for alzheimer's disease in Tampa, Florida

Image of Valley Clinical Trials, Inc. in Covina, United States.

Donanemab

Monoclonal Antibodies

Verified
Recruiting1 awardPhase 3
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Image of Weill Cornell Medicine in New York, United States.

ExAblate Model 4000 Type 2.0 System

Ultrasound Therapy

Recruiting1 award5 criteria
This trial is testing a device that uses ultrasound waves to temporarily open the brain's protective barrier in patients with Alzheimer's Disease. The goal is to see if this can help medications reach the brain better. Focused ultrasound with microbubbles has been studied recently and shows promise for opening the brain's protective barrier in Alzheimer's disease treatment.
Image of University of South Florida in Tampa, United States.

Computerized Cognitive Stimulation +1 More

Behavioural Intervention

Recruiting2 awardsPhase 3
This trial will test if a cognitive training technique can help delay the onset of mild cognitive impairment or dementia.
Image of Clinical Research Site in Birmingham, United States.

AVP-786

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.
Image of MD First Research - Chandler in Chandler, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing different doses of donanemab, a drug aimed at helping people with early Alzheimer's disease. Donanemab has shown rapid reduction of brain amyloid in early Alzheimer's disease. The study will look at how often and how severely participants experience a side effect involving brain swelling. Researchers also want to find out which patient characteristics might predict this side effect.
Image of Clinical Research Site in Phoenix, United States.

AVP-786

Behavioural Intervention

Verified
Recruiting1 awardPhase 3
This trial tests a combination of two drugs taken by mouth to help calm severe agitation in people with Alzheimer's disease by balancing brain chemicals.
Image of Irvine Clinical Research Center in Irvine, United States.

Placebo +1 More

Recruiting0 awardsPhase 2
This trial is testing a new drug, LY3372689, on people with early symptoms of Alzheimer's Disease to see if it is safe and how it affects their symptoms.
Image of North County Neurology Associates in Carlsbad, United States.

Placebo +2 More

Recruiting1 awardPhase 3
This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.
Image of Sante Cannabis in Montréal, Canada.

IGC-AD1

Cannabinoid

Recruiting0 awardsPhase 2
This trial tests a natural THC-based medicine called IGC-AD1, given in small doses regularly. It targets people aged 60 and above with Alzheimer's-related dementia who have been experiencing agitation. The THC in the medicine helps reduce agitation by interacting with brain signals. The most recent trial reported significant improvement in agitation using nabilone.
Image of Sunwise Clinical Research in Walnut Creek, United States.

NMRA-323511

Behavioural Intervention

Verified
Recruiting0 awardsPhase 1
This trial has two parts, Part A and Part B. Part A is focused on testing the safety, tolerability, and how the body processes a drug called NMRA-323511 in healthy

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.